Investing.com – Israel stocks were higher after the close on Wednesday, as gains in the Banking, Financials and Insurance sectors led shares higher. At the close in Tel Aviv, the...
Investing.com – Israel stocks were higher after the close on Thursday, as gains in the Insurance, Communication and Biomed sectors led shares higher. At the close in Tel Aviv, the...
Investing.com - Stocks enjoyed a solid rally Wednesday as Apple (NASDAQ:AAPL) and many chip stocks, along with Boeing (NYSE:BA), attracted investor interest. The rally brought the...
Perrigo Company plc (NYSE:PRGO) reported second-quarter 2019 adjusted earnings of 86 cents per share, which beat the Zacks Consensus Estimate of 81 cents. However, the bottom...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Sell||Sell||Neutral||Strong Buy||Sell|
|Technical Indicators||Strong Sell||Strong Sell||BUY||Strong Buy||Strong Sell|
|Summary||Strong Sell||Strong Sell||Neutral||Strong Buy||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Upside Gap Three Methods||1M||1||Aug 19|
|Three Inside Up||1H||7||Sep 20, 2019 09:00AM|
|Advance Block Bearish||30||7||Sep 20, 2019 12:30PM|
|Three Stars in the South||15||7||Sep 20, 2019 02:15PM|
|Bullish doji Star||1H||8||Sep 19, 2019 06:00PM|
|Bank of America||29.59||30.13||29.57||-0.23||-0.77%||167.80M||20/09|
Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences. It manufactures OTC healthcare products and supplies infant formulas for the store brand market. It is also a provider of generic extended topical prescription products. The CHC segment is focused on the sale of OTC store brand products. The BCH segment develops, manufactures, markets and distributes various European OTC brands. The Rx segment develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs. The Specialty Sciences segment consists of assets focused on the treatment of multiple sclerosis, specifically in connection with the drug, Tysabri.Read More
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.